Short Interest in CSL Limited (OTCMKTS:CSLLY) Rises By 151.1%

CSL Limited (OTCMKTS:CSLLY) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 11,800 shares, a growth of 151.1% from the December 15th total of 4,700 shares. Based on an average trading volume of 159,800 shares, the days-to-cover ratio is currently 0.1 days.

CSL Price Performance

CSLLY stock opened at $87.26 on Thursday. CSL has a 12-month low of $83.31 and a 12-month high of $109.00. The company has a quick ratio of 0.97, a current ratio of 2.18 and a debt-to-equity ratio of 0.58. The stock’s 50 day simple moving average is $89.40 and its 200 day simple moving average is $96.63.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.